Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
CML patients with stable response may safely decrease dose of TKI
Prof Mhairi Copland - University of Glasgow, Glasgow, UK
CML patients with stable response may safely decrease dose of TKI ( Prof Mhairi Copland - University of Glasgow, Glasgow, UK )
3 Dec 2016
Vadastuximab talirine in combination for newly diagnosed AML
Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Vadastuximab talirine in combination for newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016
Novel antibody boosts responses in newly diagnosed AML
Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Novel antibody boosts responses in newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016
Anti CD22 CAR T cell therapy for relapsed paediatric ALL
Dr Nirali Shah - National Cancer Institute, Bethesda, USA
Anti CD22 CAR T cell therapy for relapsed paediatric ALL ( Dr Nirali Shah - National Cancer Institute, Bethesda, USA )
3 Dec 2016
A new spin on leukaemia therapy
Prof Armand Keating - University of Toronto, Toronto, Canada
A new spin on leukaemia therapy ( Prof Armand Keating - University of Toronto, Toronto, Canada )
3 Dec 2016
Subgroup analysis of elderly high risk AML patients receiving CPX-351
Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
Subgroup analysis of elderly high risk AML patients receiving CPX-351 ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
3 Dec 2016
Remissions following anti-CD22 CAR therapy in children with relapsed ALL
Dr Terry Fry - National Cancer Institute, Bethesda, USA
Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )
3 Dec 2016
CPX-351 after stem cell transplant for elderly patients with AML
Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
CPX-351 after stem cell transplant for elderly patients with AML ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
3 Dec 2016
Involving young people in cancer research
Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK
Involving young people in cancer research ( Lorna Fern - Teenage and Young Adult Clinical Studies Group, NCRI, UK )
23 Nov 2016
AML: Is less as good as more?
Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA
AML: Is less as good as more? ( Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA )
22 Nov 2016
The creation of SIOG, and a systematic review of the AML literature
Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA
The creation of SIOG, and a systematic review of the AML literature ( Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA )
22 Nov 2016
Multiple myeloma in the elderly
Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA
Multiple myeloma in the elderly ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )
22 Nov 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation